Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial

scientific article published on 9 October 2012

Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1464-410X.2012.11547.X
P698PubMed publication ID23046147

P50authorKristian Vinter JuulQ45329296
P2093author name stringOsamu Yamaguchi
Osamu Nishizawa
Jens Peter Nørgaard
P2860cites workEfficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.Q43993185
Diurnal variation in the levels of antidiuretic hormone in the elderlyQ44357373
Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in womenQ44637304
Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trialQ48252319
Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapyQ48498566
Multifactorial nature of male nocturiaQ48510065
Gender difference in antidiuretic response to desmopressin.Q51497693
X-inactivation profile reveals extensive variability in X-linked gene expression in femalesQ22122481
The effect of nocturia on sleepQ24632849
The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence SocietyQ28215611
Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptomsQ28289969
X inactivation, female mosaicism, and sex differences in renal diseasesQ37151640
Desmopressin 30 years in clinical use: a safety reviewQ37239503
Nocturia: a non-specific but important symptom of urological diseaseQ37396037
Nocturia research: current status and future perspectivesQ37739968
The prevalence and causes of nocturiaQ37771607
Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant?Q37868803
Correlates for nocturia: a review of epidemiological studiesQ37975258
Antidiuretic hormone in elderly male patients with severe nocturia: a circadian studyQ38516610
Clinical guidelines for nocturiaQ43087475
P433issue3
P921main subjectnocturiaQ1426443
desmopressinQ241006
placeboQ269829
P304page(s)474-484
P577publication date2012-10-09
P1433published inBJU InternationalQ4835773
P1476titleGender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial
P478volume111

Reverse relations

cites work (P2860)
Q46041029A practical approach to the management of nocturia
Q47750340Desmopressin for treating nocturia in men.
Q48504091Diagnostic and therapeutic recommendations for patients with nocturia.
Q92522643Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group
Q38907923Nocturia: aetiology and treatment in adults
Q47999314Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study
Q38227703The evaluation and management of persistent nocturia
Q47696149Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia.

Search more.